Benidipine is a synthetic dihydropyridine calcium channel blocker primarily prescribed for the treatment of hypertension and angina pectoris by inhibiting L-type calcium channels. This category offers… Read more













Benidipine is a synthetic dihydropyridine calcium channel blocker primarily prescribed for the treatment of hypertension and angina pectoris by inhibiting L-type calcium channels. This category offers high-quality reference standards for pharmaceutical laboratories requiring precise analytical support, including Benidipine API, its pharmacopeial and non-pharmacopeial impurities, and various diastereomeric forms. These materials are essential for rigorous impurity profiling, method validation, and stability testing throughout the drug development lifecycle. Laboratories also utilize stable isotope-labelled compounds, such as deuterium-labelled Benidipine, as internal standards in mass spectrometry and chromatographic assays to ensure accurate quantification and regulatory compliance in quality control. By providing access to comprehensive impurity standards—including nitroso derivatives, oxidative degradation products, and related structural analogues—this selection enables comprehensive characterization and the maintenance of safety standards for pharmaceutical products containing this active ingredient.